Area of research
Parasitology · Ecology
Research interest
Research interests include Virology, Immunology, Hookworm infection, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Antibody, and Medicine.
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans
Precise targeting of HIV broadly neutralizing antibody precursors in humans
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
Vaccination induces HIV broadly neutralizing antibody precursors in humans
Human challenge trials in vaccine development, Rockville, MD, USA, September 28–30, 2017
The Global Economic and Health Burden of Human Hookworm Infection
The Human Hookworm Vaccine
Serum <scp>CCL</scp>11 (eotaxin‐1) and <scp>CCL</scp>17 (<scp>TARC</scp>) are serological indicators of multiple helminth infections and are driven by <i>Schistosoma mansoni</i> infection in humans
Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: Implications for the development of vaccines against helminths